MAJOR LEAGUE FOOTBALL INC

$ Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000164033421002194 Filed on September 14, 2021

Income Statement

Concept	2021 Q3	2020 Q3

Balance Sheet

Concept	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.300K	$80.00
YoY Change	5275.0%	-98.83%
Cash & Equivalents	$4.295K	$81.00
Short-Term Investments
Other Short-Term Assets	$52.50K	$52.50K
YoY Change	0.0%	5.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$56.80K	$52.58K
YoY Change	8.02%	-7.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$57.22K	$57.22K
YoY Change	0.0%	-70.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$11.61K	$11.52K
YoY Change	0.78%	-67.09%
Total Long-Term Assets	$70.83K	$70.74K
YoY Change	0.13%	-69.6%
TOTAL ASSETS
Total Short-Term Assets	$56.80K	$52.58K
Total Long-Term Assets	$70.83K	$70.74K
Total Assets	$127.6K	$123.3K
YoY Change	3.49%	-57.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.652M	$1.702M
YoY Change	-2.93%	-3.13%
Accrued Expenses	$343.8K	$1.323M
YoY Change	-74.0%	5.89%
Deferred Revenue
YoY Change
Short-Term Debt	$1.093M	$730.1K
YoY Change	49.75%	2.4%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.648M	$4.127M
YoY Change	12.61%	2.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.648M	$4.127M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$4.648M	$4.127M
YoY Change	12.61%	2.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.55M
YoY Change
Common Stock	$433.4K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.520M	-$4.004M
YoY Change
Total Liabilities & Shareholders Equity	$127.6K	$123.3K
YoY Change	3.49%	-57.41%

Cashflow Statement

Concept	2021 Q3	2020 Q3

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	448506737	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4295	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19778	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	52500	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	52500	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	56795	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	72278	USD
CY2021Q3	mlfb	Football Equipment FootballEquipment	46223	USD
CY2021Q2	mlfb	Football Equipment FootballEquipment	46223	USD
CY2021Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	11000	USD
CY2021Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	11000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57223	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57223	USD
CY2021Q3	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	2000	USD
CY2021Q2	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	2000	USD
CY2021Q3	mlfb	Security Deposits SecurityDeposits	11607	USD
CY2021Q2	mlfb	Security Deposits SecurityDeposits	11607	USD
CY2021Q3	us-gaap	Other Assets OtherAssets	13607	USD
CY2021Q2	us-gaap	Other Assets OtherAssets	13607	USD
CY2021Q3	us-gaap	Assets Assets	127625	USD
CY2021Q2	us-gaap	Assets Assets	143108	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1652054	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1641838	USD
CY2021Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	189068	USD
CY2021Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	177868	USD
CY2021Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	740000	USD
CY2021Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	740000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	343847	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	338251	USD
CY2021Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	110154	USD
CY2021Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	110154	USD
CY2021Q3	mlfb	Convertible Unsecured Promissory Notes Net Debt Discounts ConvertibleUnsecuredPromissoryNotesNetDebtDiscounts	120031	USD
CY2021Q2	mlfb	Convertible Unsecured Promissory Notes Net Debt Discounts ConvertibleUnsecuredPromissoryNotesNetDebtDiscounts	54942	USD
CY2021Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	517684	USD
CY2021Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	351595	USD
CY2021Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	53333	USD
CY2021Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	53333	USD
CY2021Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	133333	USD
CY2021Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	133333	USD
CY2021Q3	mlfb	Conversion Options Liability ConversionOptionsLiability	187767	USD
CY2021Q2	mlfb	Conversion Options Liability ConversionOptionsLiability	208503	USD
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	387300	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	332300	USD
CY2021Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	55000	USD
CY2021Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	55000	USD
CY2021Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	37111	USD
CY2021Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	37111	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	287948	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	261289	USD
CY2021Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	6415	USD
CY2021Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5029	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4647681	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4392271	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	434902102	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	419562102	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	433402102	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	418062102	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	433402	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	418062	USD
CY2020Q3	mlfb	Issuance Of Common Stock0004 Per Share Amount IssuanceOfCommonStock0004PerShareAmount	400	USD
CY2020Q3	mlfb	Reduction In Fair Value Of Conversion Option Liability For Conversion Of Promissory Notes ReductionInFairValueOfConversionOptionLiabilityForConversionOfPromissoryNotes	30795	USD
CY2021Q2	mlfb	Common Stock Issuable0 And40000 Shares At July312021 And April302021 Respectively CommonStockIssuable0And40000SharesAtJuly312021AndApril302021Respectively	40	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24600248	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-4249163	USD
CY2021Q3	mlfb	Common Stock Issuable CommonStockIssuable	0	USD
CY2021Q2	mlfb	Common Stock Issuable CommonStockIssuable	40000	USD
CY2021Q3	mlfb	Common Stock Issuable0 And40000 Shares At July312021 And April302021 Respectively CommonStockIssuable0And40000SharesAtJuly312021AndApril302021Respectively	0	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24325517	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29553706	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28992782	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-4520056	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-4249163	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	127625	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	143108	USD
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	83906	USD
CY2020Q3	us-gaap	Professional Fees ProfessionalFees	83184	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	331304	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36181	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	415210	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	119365	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-415210	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-119365	USD
CY2021Q3	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	5597	USD
CY2020Q3	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	5272	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	105853	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	36196	USD
CY2021Q3	mlfb	Settlement Expense And Cancellation Of Accounts Payable SettlementExpenseAndCancellationOfAccountsPayable	-55000	USD
CY2020Q3	mlfb	Settlement Expense And Cancellation Of Accounts Payable SettlementExpenseAndCancellationOfAccountsPayable	0	USD
CY2021Q3	us-gaap	Other Expenses OtherExpenses	0	USD
CY2020Q3	us-gaap	Other Expenses OtherExpenses	3750	USD
CY2021Q3	mlfb	Gain From Change In Fair Value Of Conversion Option Liability GainFromChangeInFairValueOfConversionOptionLiability	20736	USD
CY2020Q3	mlfb	Gain From Change In Fair Value Of Conversion Option Liability GainFromChangeInFairValueOfConversionOptionLiability	351784	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-145714	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	306566	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-560924	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	187201	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	424119493	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	241338556	shares
CY2021Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	424119493	shares
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	425921715	shares
CY2021Q3	mlfb	Issuance Of Common Stock That Was Previously Issuable Amount IssuanceOfCommonStockThatWasPreviouslyIssuableAmount	0	USD
CY2021Q3	mlfb	Issuance Of Common Stock To Consultants For Services Amount IssuanceOfCommonStockToConsultantsForServicesAmount	191250	USD
CY2021Q3	mlfb	Issuance Of Warrants To Consultants For Services00125 Per Share IssuanceOfWarrantsToConsultantsForServices00125PerShare	98781	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-560924	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-4520056	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-4590509	USD
CY2020Q3	mlfb	Conversion Of Convertible Secured Promissory Note Amount ConversionOfConvertibleSecuredPromissoryNoteAmount	10920	USD
CY2020Q3	mlfb	Reclassification Of Put Premium Upon Conversion Of Convertible Secured Promissory Notes1 ReclassificationOfPutPremiumUponConversionOfConvertibleSecuredPromissoryNotes1	4382	USD
CY2020Q3	mlfb	Conversion Of Convertible Unsecured Promissory Notes Amount ConversionOfConvertibleUnsecuredPromissoryNotesAmount	168398	USD
CY2020Q3	mlfb	Reclassification Of Put Premium Upon Conversion Of Convertible Unsecured Promissory Note ReclassificationOfPutPremiumUponConversionOfConvertibleUnsecuredPromissoryNote	144366	USD
CY2020Q3	mlfb	Issuance Of Common Stock004 Per Share Amount IssuanceOfCommonStock004PerShareAmount	40000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	187201	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-4004047	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-560924	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	187201	USD
CY2021Q3	mlfb	Amortization Of Debt Discount On Convertible Unsecured Promissory Notes AmortizationOfDebtDiscountOnConvertibleUnsecuredPromissoryNotes	3756	USD
CY2021Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2020Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021Q3	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2020Q3	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q3	mlfb	Reduction Of Put Premium Liability Related To Conversion Of Promissory Notes ReductionOfPutPremiumLiabilityRelatedToConversionOfPromissoryNotes	0	USD
CY2020Q3	mlfb	Reduction Of Put Premium Liability Related To Conversion Of Promissory Notes ReductionOfPutPremiumLiabilityRelatedToConversionOfPromissoryNotes	148748	USD
CY2020Q3	mlfb	Amortization Of Debt Discount On Convertible Unsecured Promissory Notes AmortizationOfDebtDiscountOnConvertibleUnsecuredPromissoryNotes	4010	USD
CY2021Q3	mlfb	Issuance Of Common Stock To Consultants For Services IssuanceOfCommonStockToConsultantsForServices	191250	USD
CY2020Q3	mlfb	Issuance Of Common Stock To Consultants For Services IssuanceOfCommonStockToConsultantsForServices	0	USD
CY2021Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	98781	USD
CY2020Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2021Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	55000	USD
CY2020Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	0	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3750	USD
CY2021Q3	us-gaap	Liability For Future Policy Benefit Expected Net Premium Period Increase Decrease LiabilityForFuturePolicyBenefitExpectedNetPremiumPeriodIncreaseDecrease	67333	USD
CY2020Q3	us-gaap	Liability For Future Policy Benefit Expected Net Premium Period Increase Decrease LiabilityForFuturePolicyBenefitExpectedNetPremiumPeriodIncreaseDecrease	0	USD
CY2021Q3	mlfb	Loss Gain From Change In Fair Value Of Conversion Option Liability LossGainFromChangeInFairValueOfConversionOptionLiability	-20736	USD
CY2020Q3	mlfb	Loss Gain From Change In Fair Value Of Conversion Option Liability LossGainFromChangeInFairValueOfConversionOptionLiability	-351784	USD
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10216	USD
CY2020Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	54070	USD
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	11200	USD
CY2020Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	27900	USD
CY2021Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5596	USD
CY2020Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5271	USD
CY2021Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	26659	USD
CY2020Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	24837	USD
CY2021Q3	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1386	USD
CY2020Q3	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	630	USD
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-110483	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44115	USD
CY2021Q3	mlfb	Proceeds From Issuance Of Convertible Unsecured Promissory Notes Net Of Issue Costs ProceedsFromIssuanceOfConvertibleUnsecuredPromissoryNotesNetOfIssueCosts	95000	USD
CY2020Q3	mlfb	Proceeds From Issuance Of Convertible Unsecured Promissory Notes Net Of Issue Costs ProceedsFromIssuanceOfConvertibleUnsecuredPromissoryNotesNetOfIssueCosts	0	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40400	USD
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	95000	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40400	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-15483	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3715	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19778	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3796	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4295	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81	USD
CY2021Q3	mlfb	Reduction In Fair Value Of Conversion Option Liability For Conversion Of Promissory Note ReductionInFairValueOfConversionOptionLiabilityForConversionOfPromissoryNote	0	USD
CY2020Q3	mlfb	Reduction In Fair Value Of Conversion Option Liability For Conversion Of Promissory Note ReductionInFairValueOfConversionOptionLiabilityForConversionOfPromissoryNote	30795	USD
CY2021Q3	mlfb	Conversion Of Convertible Secured Promissory Note ConversionOfConvertibleSecuredPromissoryNote	0	USD
CY2020Q3	mlfb	Conversion Of Convertible Secured Promissory Note ConversionOfConvertibleSecuredPromissoryNote	10920	USD
CY2021Q3	mlfb	Conversion Of Convertible Unsecured Promissory Notes ConversionOfConvertibleUnsecuredPromissoryNotes	0	USD
CY2020Q3	mlfb	Conversion Of Convertible Unsecured Promissory Notes ConversionOfConvertibleUnsecuredPromissoryNotes	145233	USD
CY2021Q3	mlfb	Conversion Of Accrued Interest On Convertible Unsecured Promissory Notes ConversionOfAccruedInterestOnConvertibleUnsecuredPromissoryNotes	0	USD
CY2020Q3	mlfb	Conversion Of Accrued Interest On Convertible Unsecured Promissory Notes ConversionOfAccruedInterestOnConvertibleUnsecuredPromissoryNotes	19415	USD
CY2021Q3	mlfb	Discounts Related To Convertible Promissory Notes DiscountsRelatedToConvertiblePromissoryNotes	6000	USD
CY2020Q3	mlfb	Discounts Related To Convertible Promissory Notes DiscountsRelatedToConvertiblePromissoryNotes	0	USD
CY2021Q3	mlfb	Net Loss NetLoss	-560924	USD
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-110483	USD
CY2021Q3	mlfb	Working Capital WorkingCapital	-4590886	USD
CY2021Q3	mlfb	Accumulated Deficit AccumulatedDeficit	-29553706	USD
CY2021Q3	mlfb	Stockholders Deficit StockholdersDeficit	-4520056	USD
CY2021Q3	mlfb	Short Term Finance ShortTermFinance	3000000	USD
CY2021Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results could differ from the estimates. Significant estimates in the accompanying unaudited financial statements include the valuation of derivative liabilities, estimates of loss contingencies, valuation of equity-based instruments issued for other than cash and valuation allowance on deferred tax assets. </p>
CY2021Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash. At July 31, 2021 and April 30, 2021, the Company did not have deposits with a financial institution that exceeded the FDIC deposit insurance coverage and determined that it had no cash equivalents.</p>
CY2021Q3	mlfb	Football Equipments FootballEquipments	57223	USD
CY2021Q3	mlfb	Convertible Promissory Notes And Related Embedded Derivatives Policy Text Block Ed ConvertiblePromissoryNotesAndRelatedEmbeddedDerivativesPolicyTextBlockED	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We account for the embedded conversion option contained in convertible instruments under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”. The embedded conversion option contained in the convertible instruments were accounted for as derivative liabilities at the date of issuance and shall be adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option derivatives was determined using the Binomial Option Pricing model. On the initial measurement date, the fair value of the embedded conversion option derivative was recorded as a derivative liability and was allocated as debt discount up to the proceeds of the notes with the remainder charged to current period operations as initial derivative expense. Any gains and losses recorded from changes in the fair value of the liability for derivative contract is recorded as a component of other income (expense) in the accompanying unaudited Statements of Operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.35pt; text-align:justify;">The Company follows ASU 260 regarding changes to the classification of certain equity-linked financial instruments (or embedded features) with down round features and clarifies existing disclosure requirements for equity-classified instruments. For freestanding equity-classified financial instruments, entities that present earnings per share (“EPS”) in accordance with Topic 260, to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features would be subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related guidance in Topic 260.</p>
CY2021Q3	mlfb	Conversion Option Liabilities ConversionOptionLiabilities	187767	USD
CY2021Q2	mlfb	Conversion Option Liabilities ConversionOptionLiabilities	208503	USD
CY2021Q3	mlfb	Scheduleofconversionoptionliability Tabletextblock ScheduleofconversionoptionliabilityTabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Conversion Option Liability</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Balance – April 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">208,503</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Gain from change in the fair value of conversion option liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(20,736</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Balance – July 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">187,767</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021Q3	mlfb	Beginning Balance BeginningBalance	208503	USD
CY2021Q3	mlfb	Gain From Change In The Fair Value Of Conversion Option Liability GainFromChangeInTheFairValueOfConversionOptionLiability	-20736	USD
CY2021Q3	mlfb	Ending Balance EndingBalance	187767	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	187201	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	241338556	shares
CY2020Q3	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	119384456	USD
CY2020Q3	mlfb	Convertible Secured Notes Payable ConvertibleSecuredNotesPayable	65198703	USD
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	425921715	shares
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q3	mlfb	Stock Options Purchase StockOptionsPurchase	1200000	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.05
CY2020Q3	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	1800000	shares
CY2020Q3	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	0.13
CY2020Q3	mlfb	Unsecured Promissory Note UnsecuredPromissoryNote	50000	USD
CY2021Q3	us-gaap	Debt Conversion Original Debt Interest Rate Of Debt DebtConversionOriginalDebtInterestRateOfDebt	0.0030	pure
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	202510	shares
CY2020Q3	mlfb	Stock Options Purchase StockOptionsPurchase	1200000	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	9650000	shares
CY2021Q3	mlfb	Issuance Of Common Stock Shares Related To Convertible Debt IssuanceOfCommonStockSharesRelatedToConvertibleDebt	76671309	shares
CY2021Q3	mlfb	Unsecured Promissory Note UnsecuredPromissoryNote	40610145	USD
CY2021Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	266683	USD
CY2021Q2	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	261087	USD
CY2021Q3	mlfb	Unpaid Federal Income Tax UnpaidFederalIncomeTax	1764	USD
CY2021Q2	mlfb	Unpaid Federal Income Tax UnpaidFederalIncomeTax	1764	USD
CY2021Q3	mlfb	Legal Settlement LegalSettlement	70000	USD
CY2021Q2	mlfb	Legal Settlement LegalSettlement	70000	USD
CY2021Q3	mlfb	Late Charges On Unpaid Promissory Notes LateChargesOnUnpaidPromissoryNotes	5400	USD
CY2021Q2	mlfb	Late Charges On Unpaid Promissory Notes LateChargesOnUnpaidPromissoryNotes	5400	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	343847	USD
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	338251	USD
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	387300	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	332300	USD
CY2021Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	387300	USD
CY2021Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	332300	USD
CY2021Q3	mlfb	Principal Amount PrincipalAmount	232300	USD
CY2020Q1	mlfb	Default Accrued Interest Rate DefaultAccruedInterestRate	0.24	pure
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	9376	USD
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	8166	USD
CY2021Q3	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	110193	USD
CY2021	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	100817	USD
CY2021Q3	mlfb	Notes Payable Related Party NotesPayableRelatedParty	55000	USD
CY2021Q2	mlfb	Notes Payable Related Party NotesPayableRelatedParty	55000	USD
CY2021Q3	mlfb	Accrued Interest Related Party AccruedInterestRelatedParty	6415	USD
CY2021Q2	mlfb	Accrued Interest Related Party AccruedInterestRelatedParty	5029	USD
CY2021Q3	mlfb	Convertible Secured Note Payable Principal And Interest At8 Due May172019 Interest Recorded At Default Rate Of18 ConvertibleSecuredNotePayablePrincipalAndInterestAt8DueMay172019InterestRecordedAtDefaultRateOf18	80000	USD
CY2021Q2	mlfb	Convertible Secured Note Payable Principal And Interest At8 Due May172019 Interest Recorded At Default Rate Of18 ConvertibleSecuredNotePayablePrincipalAndInterestAt8DueMay172019InterestRecordedAtDefaultRateOf18	80000	USD
CY2021Q3	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	53333	USD
CY2021Q2	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	53333	USD
CY2021Q3	mlfb	Convertible Secured Promissory Note ConvertibleSecuredPromissoryNote	133333	USD
CY2021Q2	mlfb	Convertible Secured Promissory Note ConvertibleSecuredPromissoryNote	133333	USD
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	434902102	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	433402102	shares
CY2021Q2	mlfb	Common Stock Shares Issuable CommonStockSharesIssuable	40000	shares
CY2021Q3	us-gaap	Option Indexed To Issuers Equity Strike Price1 OptionIndexedToIssuersEquityStrikePrice1	0.0125
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.070
CY2021Q3	mlfb	Fair Value Assumption Expected Term FairValueAssumptionExpectedTerm	P2Y8M4D
CY2021Q3	mlfb	Fair Value Assumption Expected Volatility Rate FairValueAssumptionExpectedVolatilityRate	3.02	pure
CY2021Q3	mlfb	Fair Value Assumption Expected Dividend Rate FairValueAssumptionExpectedDividendRate	0.0000	pure
CY2021Q3	mlfb	Fair Value Assumption Risk Free Interest Rate FairValueAssumptionRiskFreeInterestRate	0.0001	pure
CY2021Q3	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	189068	USD
CY2021Q2	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	177868	USD
CY2021Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.10	pure
CY2021Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2021-10-31
CY2021Q3	mlfb	Accrued Interest Related Party AccruedInterestRelatedParty	6415	USD
CY2021Q2	mlfb	Accrued Interest Related Party AccruedInterestRelatedParty	5029	USD
CY2021Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	110154	USD
CY2018Q2	mlfb	Convertible Secured Promissory Notes ConvertibleSecuredPromissoryNotes	80000	USD
CY2018Q2	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal	30000	USD

Files In Submission

Name	View Source	Status
0001640334-21-002194-index-headers.html	Edgar Link	pending
0001640334-21-002194-index.html	Edgar Link	pending
0001640334-21-002194.txt	Edgar Link	pending
0001640334-21-002194-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mlfb-20210731.xsd	Edgar Link	pending
mlfb-20210731_cal.xml	Edgar Link	unprocessable
mlfb-20210731_def.xml	Edgar Link	unprocessable
mlfb-20210731_lab.xml	Edgar Link	unprocessable
mlfb-20210731_pre.xml	Edgar Link	unprocessable
mlfb_10q.htm	Edgar Link	pending
mlfb_10q_htm.xml	Edgar Link	completed
mlfb_ex31.htm	Edgar Link	pending
mlfb_ex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

MAJOR LEAGUE FOOTBALL INC

2021 Q3 Form 10-Q Financial Statement

#000164033421002194 Filed on September 14, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission